Partho Sengupta, MD, an expert on the use of AI in cardiology, says some of the technologies being developed today will fundamentally change how cardiologists and sonographers do their jobs.
Serious discrepancies between preliminary imaging reads and final radiology reports are at risk of accumulating when the prelims are rendered during overnight hours.
Scientists believe this is the first series demonstrating a significant survival difference in patients monitored with an intensive follow-up strategy via 18F-fludeoxyglucose–positron emission tomography.
Scientists at Houston Methodist Hospital developed the intelligent-augmented breast cancer risk calculator, testing it across a large dataset to produce promising results.
Given the approach’s “superior prognostic value,” experts urged for the incorporation of tau PET into routine clinical evaluation in memory care clinics.
The contrast agent, simply called Gadobutrol Injection, has been approved by the U.S. Food and Drug Administration and is now available in the United States.
Representative transverse dynamic contrast-enhanced MRI scans in patients in the high (left) and low (right) tertiles of volume of enhancing parenchyma.
A new AI model helped researchers identify a relationship between background parenchyma enhancement on breast MRI exams and breast cancer risk.